Corrigendum to “Real-World Effectiveness of Ocrelizumab in Relapsing Multiple Sclerosis: An MSBase Registry Sub-Study” [Multiple Sclerosis and Related Disorders Vol 106

dc.contributor.author Butzkueven, Helmut
dc.contributor.author Taylor, Lisa
dc.contributor.author Spelman, Tim
dc.contributor.author Kalincik, Tomas
dc.contributor.author Boz, Cavit
dc.contributor.author Ozakbas, Serkan
dc.contributor.author Farr, Pamela
dc.date.accessioned 2026-04-25T10:17:34Z
dc.date.available 2026-04-25T10:17:34Z
dc.date.issued 2026-05
dc.description.sponsorship Roche; Nucleus Global
dc.description.sponsorship The OCR-R MSBase substudy is financially supported by F. Hoffmann-La Roche Ltd, Basel, Switzerland. Writing and editorial assistance were provided by Nucleus Global and funded by F. Hoffmann-La Roche Ltd.
dc.description.sponsorship We would like to thank all patients, their families, and the investigators who participated in this study. Editorial support (including assistance with revisions to the manuscript for non-intellectual content, figure redraws, and copy editing) was provided by Nucleus Global, and funded by F. Hoffmann-La Roche Ltd.
dc.identifier.doi 10.1016/j.msard.2026.107131
dc.identifier.issn 2211-0348
dc.identifier.scopus 2-s2.0-105035174525
dc.identifier.uri https://hdl.handle.net/20.500.14365/8991
dc.identifier.uri https://doi.org/10.1016/j.msard.2026.107131
dc.language.iso en
dc.publisher Elsevier B.V.
dc.relation.ispartof Multiple Sclerosis and Related Disorders
dc.rights info:eu-repo/semantics/openAccess
dc.title Corrigendum to “Real-World Effectiveness of Ocrelizumab in Relapsing Multiple Sclerosis: An MSBase Registry Sub-Study” [Multiple Sclerosis and Related Disorders Vol 106 en_US
dc.title Feb 2026 en_US
dc.title Article Number 106885] (Multiple Sclerosis and Related Disorders (2026) 106, (S2211034825006236), (10.1016/j.Msard.2025.106885)) en_US
dc.type Erratum
dspace.entity.type Publication
gdc.author.scopusid 57201788612
gdc.author.scopusid 57214223148
gdc.author.scopusid 59937262500
gdc.author.scopusid 6602895100
gdc.author.scopusid 6701728553
gdc.author.scopusid 8365701900
gdc.author.scopusid 25623864800
gdc.description.department
gdc.description.departmenttemp [Butzkueven H.] Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia, MSBase Foundation, Alfred Centre, Melbourne, Australia; [Farr P.] MSBase Foundation, Alfred Centre, Melbourne, Australia; [Ozakbas S.] Izmir University of Economics, Medical Point Hospital, Izmir, Turkey; [Boz C.] Department of Neurology, Medical Faculty, Karadeniz Technical University, Trabzon, Turkey; [Kalincik T.] CORe, Department of Medicine, University of Melbourne, Melbourne, Australia, Neuroimmunology Centre, Royal Melbourne Hospital, Melbourne, Australia; [Taylor L.] CORe, Department of Medicine, University of Melbourne, Melbourne, Australia; [Van Der Walt A.] Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia, MSBase Foundation, Alfred Centre, Melbourne, Australia; [Alroughani R.] Amiri Hospital, Sharq, Qurtoba, Kuwait; [Buzzard K.] Dept Neurosciences, Eastern Health Clinical School, Monash University, Box Hill Hospital, Australia; [Skibina O.] Dept Neurosciences, Eastern Health Clinical School, Monash University, Box Hill Hospital, Australia; [Lechner-Scott J.] University Newcastle, Newcastle, Australia; [Laureys G.] Ghent University Hospital, Ghent, Belgium; [Terzi M.] Ondokuz Mayis University, Medical Faculty, Department of Neurology, Samsun, Turkey; [Van Pesch V.] Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; [Grand-Maison F.] Neuro Rive-Sud, Greenfield Park, QC, Canada; [Barnett M.] Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia; [Kermode A.] University of Western Australia, Nedlands, Australia; [Menoyo J.L.S.] Hospital de Galdakao-Usansolo, Galdakao, Spain; [Rojas J.] Hospital Universitario de CEMIC, Buenos Aires, Argentina; [Willekens B.] Antwerp University Hospital, Edegem, Belgium; [Foschi M.] Department of Neuroscience, MS Center, Neurology Unit, S. Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy; [Ramo-Tello C.] Hospital Germans Trias i Pujol, Badalona, Spain; [Skromne E.] Hospital Angeles de las Lomas, Instituto Mexicano de Neurociencias, Valle de las Palmas, Mexico; [Dirks P.] F. Hoffmann-La Roche Ltd, Basel, Switzerland; [Rouzic E.M.-L.] F. Hoffmann-La Roche Ltd, Basel, Switzerland; [Spelman T.] Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
gdc.description.volume 109
gdc.identifier.pmid 41963004
gdc.index.type PubMed
gdc.index.type Scopus
gdc.virtual.author Özakbaş, Serkan
relation.isAuthorOfPublication 0750ade3-1d29-450d-8c26-aaa8708d1bb0
relation.isAuthorOfPublication.latestForDiscovery 0750ade3-1d29-450d-8c26-aaa8708d1bb0
relation.isOrgUnitOfPublication 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd
relation.isOrgUnitOfPublication fbc53f3e-d1d3-4168-afd8-e42cd20bddd9
relation.isOrgUnitOfPublication e9e77e3e-bc94-40a7-9b24-b807b2cd0319
relation.isOrgUnitOfPublication.latestForDiscovery 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd

Files